ArticleCancer management and research2024

Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors.

Weixin Bei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.